---
title: "ZHYL plans to invest in SEA3 in Southeast Asia to expand its overseas business space"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/247329093.md"
description: "ZHYL announced that it will sign an agreement through its wholly-owned subsidiary ZH Hong Kong and its holding subsidiary Hengbao International to acquire 75% equity of Southeast Asia SEA3 Company for RMB 697 million and increase its capital by RMB 75.6794 million. SEA3 Company focuses on the production and sales of medical-grade gloves and has multiple international certifications. This transaction will promote resource integration and enhance the company's competitiveness in overseas markets"
datetime: "2025-07-04T13:34:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/247329093.md)
  - [en](https://longbridge.com/en/news/247329093.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/247329093.md)
generator: "portal-rs"
---

# ZHYL plans to invest in SEA3 in Southeast Asia to expand its overseas business space

According to the announcement from ZHYL (300981.SZ), in order to implement the company's strategic plan, expand overseas business space, and enhance the company's overall competitive strength, it has agreed that its subsidiary ZHYL International (Hong Kong) Trading Co., Ltd. (hereinafter referred to as "ZHYL Hong Kong", a wholly-owned subsidiary of the company) will sign a share purchase agreement and a shareholder agreement with Guilin Hengbao Protective International Co., Ltd. (hereinafter referred to as "Hengbao International", which is wholly owned by Guilin Hengbao Health Protection Co., Ltd., a holding subsidiary in which the company holds 70% of the shares). ZHYL Hong Kong will use its own funds to acquire a total of 75% equity in Southeast Asia SEA3 Company (hereinafter referred to as "the target company") for a total cash consideration of RMB 6.97 million, and it is agreed that after the equity transfer, ZHYL Hong Kong and Hengbao International (which will first increase its capital by RMB 10 million from Guilin Hengbao Health Protection Co., Ltd.) will respectively increase their capital in SEA3 Company by RMB 52.9755 million and RMB 22.7038 million, totaling a capital increase of RMB 75.6794 million.

The target company SEA3 primarily engages in the production and sales of medical-grade gloves. The target company possesses EU ISO13485 quality management system certification, EU CE certification, and US FDA 510(k) certification, among others, and has complete export qualifications for Europe and the United States.

Upon completion of this transaction, the company and SEA3 Company can achieve complementary advantages in supply chain resources, domestic and international channels, management operations, technology research and development, and high-end talent, thereby leveraging resource integration advantages

### Related Stocks

- [300981.CN](https://longbridge.com/en/quote/300981.CN.md)

## Related News & Research

- [Flexdeal chair Alberto Amaral buys EUR 150,000 in shares](https://longbridge.com/en/news/296250174.md)
- [Thales, Systematic partner to boost Danish air defense capabilities](https://longbridge.com/en/news/296363485.md)
- [Invo Fertility highlights retrospective IVF platelet-rich plasma studies at Midwest Reproductive Symposium 2026](https://longbridge.com/en/news/296495699.md)
- [Helport AI expands revenue-generating AI Labor deployments for consumer hardware customer service in North America, Europe](https://longbridge.com/en/news/296491820.md)
- [Asker Healthcare Group buys Baltic medtech distributor Ambercell Solutions](https://longbridge.com/en/news/296306272.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**